Form 13-F position report

MOLECULAR TEMPLATES INC

Reported by GILDER GAGNON HOWE & CO LLC

MTEMXXXX CUSIP 608550109 Manager CIK 0000902464

Reported 0 shares, down 126,541 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 12 Through Q2 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for MOLECULAR TEMPLATES INC held by GILDER GAGNON HOWE & CO LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

106 managers reported MOLECULAR TEMPLATES INC for Q2 2021.

Managers reporting MOLECULAR TEMPLATES INC in Q2 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Bellevue Group AG Added 9,628,621 +1,480,516 0.74% $75,296,000 7 qtrs
BVF INC IL Reduced 2,856,599 -7,700 0.84% $22,339,000 16 qtrs
VANGUARD GROUP INC Added 2,692,980 +119,107 < 0.01% $21,059,000 16 qtrs
PICTET ASSET MANAGEMENT LTD Added 2,671,504 +5,173 0.02% $20,891,000 4 qtrs
BlackRock Inc Reduced 2,653,904 -407,804 < 0.01% $20,756,000 16 qtrs
CAXTON CORP Added 2,137,991 +15,000 11.46% $16,719,000 16 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 1,243,761 +397,740 < 0.01% $9,726,000 5 qtrs
ADAGE CAPITAL PARTNERS GP L L C Added 1,015,000 +75,000 0.02% $7,937,000 2 qtrs
KINGDON CAPITAL MANAGEMENT L L C Added 1,011,495 +50,000 0.92% $7,910,000 12 qtrs
Endurant Capital Management LP Added 748,013 +38,653 1.61% $5,849,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2021
Filed
August 16, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.